Infection and invasion mechanisms of Trypanosoma cruzi in the congenital transmission of chagas' disease: A proposal

Biological Research

Volumn 43, Issue 3, 2010, Pages 307-316

  Kemmerling, Ulrike ^a,b   Bosco, Cleo ^a   Galanti, Norbel ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE TALCA   (Chile)

Author keywords

Congenital chaga ; Disease; Mechanism of infection; Tissue invasion

Indexed keywords

HEXAPODA; PROTOZOA; TRIATOMA INFESTANS; TRYPANOSOMA CRUZI;

EID: 78650111564     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602010000300007     Document Type: Review

References (127)

1. ALONSO-VEGA C, HERMANN E, TRUYENS C, RODRÍGUEZ P, TORRICO MC, TORRICO F, CARLIER Y. (2005) Immunological status of mothers infected with Trypanosoma cruzi. Rev Soc Bras Med Trop. 38 Suppl 2: 101-4.
2. ALTEMANI AM, BITTENCOURT AL, LANA AM (2000) Immunohistochemical characterization of the inflammatory infiltrate in placental chagaśdisease: A cualitative and quantitative analysis. Am J. Trop. Med. Hyg. 62(2): 319-324
3. AMINO R, MARTINS RM, PROCOPIO J, HIRATA IY, JULIANO M. (2002) Trialysin, a novel pore-forming protein from saliva of hematophagous insects activated by limited proteolysis. J Biol Chem 277: 6207-6213.
4. ANDRADE LO, ANDREWS NW. (2005) The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat Rev Microbiol. 3(10): 819-23.
5. ANDRADE SG, GRIMAUD JA, STOCKER-GUERRET S. (1989) Sequential changes of the connective matrix components of the myocardium (fibronectin and laminin) and evolution of cardiac fibrosis in mice infected with Trypanosoma cruzi. Am J Trop Med Hyg. 40(3): 252-60.
6. ANDRADE SG. The influence of the strain of Trypanosoma cruzi in placental infections in mice. (1982) Trans R Soc Trop Med Hyg 76: 123-8.
7. ANDREWS NW. (2002) Lysosomes and the plasma membrane: trypanosomes reveal a secret relationship. J Cell Biol. 158(3): 389-94.
8. AOKI MP, GUINAZU NL, PELLEGRINI AV, GOTOH T, MASIH DT, GEA S. (2004) Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes. Am J Physiol Cell Physiol 286(2): C206-12.
9. AUFDERHEIDE AC, SALO W, MADDEN M, STREITZ J, BUIKSTRA J, GUHL F, ARRIAZA B, RENIER C, WITTMERS LE JR, FORNACIARI G, ALLISON M. (2004) A 9,000-year record of Chagas' disease. Proc Natl Acad Sci U S A. 101(7): 2034-9.
10. BENYO DF, MILES TM, CONRAD KP. (1997) Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab. 82(5): 1582-8.
11. BERNISCHKE K, KAUFMANN P, BAERGEN R (2006) Pathology of the Human Placenta. Fifth Edition. Springer Science+Business Media Inc. New York
12. BIEDERMANN K, FLEPP M, FIERZ W, JOLLER-JEMELKA H, KLEIHUES P. (1995) Pregnancy, immunosuppression and reactivation of latent toxoplasmosis. J Perinat Med. 23(3): 191-203.
13. BITTENCOURT AL. (1976) Congenital Chagas' disease. Am J Dis Child 130: 97-103.
14. BLANCO SB, SEGURA EL, CURA EN, CHUIT R, TULIAN L, FLORES I (2000) Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in northwestern Argentina. Trop Med Int Health 5: 293-301.
15. BOSCO C, BUFFET C, BELLO MA, RODRIGO R, GUTIERREZ M, GARCIA G. (2007) Placentation in the degu (Octodon degus): analogies with extrasubplacental trophoblast and human extravillous trophoblast. Comp Biochem Physiol A Mol Integr Physiol. 146(4): 475-85.
16. BURGOS JM, ALTCHEH J, BISIO M, DUFFY T, VALADARES HM, SEIDENSTEIN ME, PICCINALI R, FREITAS JM, LEVIN MJ, MACCHI L, MACEDO AM, FREILIJ H, SCHIJMAN AG. (2007) Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease. Int J Parasitol. 37(12): 1319-27.
17. BURLEIGH BA, ANDREWS NW. (1995) The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Annu Rev Microbiol.49: 175-200.
18. BURLEIGH BA, WOOLSEY AM. (2002) Cell signalling and Trypanosoma cruzi invasion. Cell Microbiol. 4(11): 701-11.
19. CARLIER Y. (2005) Factors and mechanisms involved in the transmission and development of congenital infection with Trypanosoma cruzi Rev Soc Bras Med Trop. 38 Suppl 2: 105-7.
20. CASTRO JA, DE MECCA MM, BARTEL LC. (2006) Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum Exp Toxicol. 25(8): 471-9.
21. CERQUEIRA GC, BARTHOLOMEU DC, DAROCHA WD, HOU L, FREITAS-SILVA DM, MACHADO CR, EL-SAYED NM, TEIXEIRA SM. (2008) Sequence diversity and evolution of multigene families in Trypanosoma cruzi. Mol Biochem Parasitol. 157(1): 65-72.
22. CORREA D, CANEDO-SOLARES I, ORTIZ-ALEGRIA LB, CABALLEROORTEGA H, RICO-TORRES CP. (2007) Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host. Parasite Immunol. 29(12): 651-60.
23. CORTHORN J, REY S, CHACON C, VALDES G. (2007) Spatio-temporal expression of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guinea-pig (Cavia porcellus). Reprod Biol Endocrinol. Jul 2;5: 27.
24. COURA JR (2007) Chagas disease: what is known and what is needed: a background article. Mem Inst Oswaldo Cruz. Oct 30;102 Suppl 1: 113-22.
25. COURA JR. (2006) Transmission of chagasic infection by oral route in the natural history of Chagas disease Rev Soc Bras Med Trop.;39 Suppl 3: 113-7.
26. CROSS JC. (2006) Placental function in development and disease. Reprod Fertil Dev.18(1-2): 71-6.
27. CHAGAS, C. (1909). Nova tripanosomiase humana. Estudios sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n.gen, n.sp., agente etiologico do nova entidae mórbida do homen. Mem. Inst. Oswaldo Cruz 1: 159-218.
28. CHUENKOVA MV, PEREIRA MA. (2001) The T. cruzi trans-sialidase induces PC12 cell differentiation via MAPK/ERK pathway. Neuroreport. 12(17): 3715-8.
29. DE SOUZA W. (2002) From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality. Kinetoplastid Biol Dis. May 31;1(1): 3.
30. DERRIEN M, FAYE A, DOLCINI G, CHAOUAT G, BARRE-SINOUSSI F, MENU E. (2005) Impact of the placental cytokine-chemokine balance on regulation of cell-cell contact-induced human immunodeficiency virus type 1 translocation across a trophoblastic barrier in vitro. J Virol. 79(19): 12304-10.
31. DESAI M, TER KUILE FO, NOSTEN F, MCGREADY R, ASAMOA K, BRABIN B, NEWMAN RD. (2007) Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 7(2): 93-104.
32. DI NOIA JM, BUSCAGLIA CA, DE MARCHI CR, ALMEIDA IC, FRASCH AC. (2002) A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. J Exp Med.195(4): 401-13.
33. DISCHE MR, QUINN PA, CZEGLEDY-NAGY E, STURGESS JM. (1979) Genital mycoplasma infection. Intrauterine infection: pathologic study of the fetus and placenta. Am J Clin Pathol. 72(2): 167-74.
34. DUASO J, ROJO G, CABRERA G, GALANTI N, BOSCO C, MAYA JD, MORELLO A AND KEMMERLING U. (2010) "Trypanosoma cruzi induces tissue disorganization and destruction of chorionic villi in an ex vivo infection model of human placenta". Placenta 31 (8) 705-11.
35. FERNANDEZ-AGUILAR S, LAMBOT MA, TORRICO F, ALONS-OVEGA C, CÓRDOBA M, SUÁREZ E, NOEL JC, CARLIER Y. (2005) Placental lesions in human Trypanosoma cruzi infection Rev Soc Bras Med Trop. 38 Suppl 2: 84-6.
36. FRAGATA FILHO AA, CORREIA EDE B, BORGES FILHO R, VASCONCELOS M DE O, JANCZUK D, MARTINS CS. (2008) sequence of unusual Chagas infection transmissions in the same family: mother by blood transfusion and child congenitally, with a treatment-resistant strain of Trypanosoma cruzi. Rev Soc Bras Med Trop. 41(1): 73-5.
37. FREITAS JM, LAGES-SILVA E, CREMA E, PENA SD, MACEDO AM. (2005) Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues. Int J Parasitol. 35(4): 411-7.
38. FRIEDMAN JF, MITAL P, KANZARIA HK, OLDS GR, KURTIS JD. (2007) Schistosomiasis and pregnancy. Trends Parasitol. 23(4): 159-64.
39. FUJIWARA H. (2007) Membrane-bound peptidases regulate human extravillous trophoblast invasion. Placenta. 28 Suppl A: S70-5.
40. GAMAIN B, SMITH JD, VIEBIG NK, GYSIN J, SCHERF A. (2007) Pregnancyassociated malaria: parasite binding, natural immunity and vaccine development. Int J Parasitol. 37(3-4): 273-83.
41. GARCIA MM, DE RISSIO AM, VILLALONGA X, MENGONI E, CARDONI RL. (2008) Soluble tumor necrosis factor (TNF) Receptors (sTNF-R1 and -R2) in pregnant women chronically infected with Trypanosoma cruzi and their children. Am J Trop Med Hyg. 78(3): 499-503.
42. GARZONI LR, ADESSE D, SOARES MJ, ROSSI MI, BOROJEVIC R, MEIRELLES MD. (2008) Fibrosis and Hypertrophy Induced by Trypanosoma cruzi in a Three- Dimensional Cardiomyocyte-Culture System. J Infect Dis. 197(6): 906-915.
43. GEDEON C, KOREN G. (2005) Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta. 27(8): 861-8.
44. GIORDANO R, FOUTS DL, TEWARI D, COLLI W, MANNING JE AND ALVES MJM. (1999). Cloning of a surface membrane glycoprotein specific for the infective form of Trypanosoma cruzi having adhesive properties to laminin. J Biol Chem 274: 3461-3468.
45. GRIMM H. (1955) An observation on the growth-promoting and growthinhibiting substance of the placenta. Z Arztl Fortbild (Jena). 49(15-16): 531-5.
46. GOMEZ DE, ALONSO DF, YOSHIJI H, THORGEIRSSON UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74: 111-22.
47. GUILBERT L, ROBERTSON SA, WEGMANN TG. (1993) The trophoblast as an integral component of a macrophage-cytokine network. Immunol Cell Biol. 71 (Pt 1): 49-57.
48. GUTIERREZ FR, LALU MM, MARIANO FS, MILANEZI CM, CENA J, GERLACH RF, SANTOS JE, TORRESD-UENAS D, CUNHA FQ, SCHULZ R, SILVA JS. (2008) Increased Activities of Cardiac Matrix Metalloproteinases Matrix Metalloproteinase (MMP)-2 and MMP-9 Are Associated with Mortality during the Acute Phase of Experimental Trypanosoma cruzi Infection. J Infect Dis. May 15;197 (10): 1468-1476.
49. HALWACHS-BAUMANN G. (2006) The congenital cytomegalovirus infection: virus-host interaction for defense and transmission. Curr Pharm Biotechnol. 7(4): 303-12.
50. HALL BS, TAM W, SEN R, PEREIRA ME. (2000) Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection. Mol Biol Cell. 11(1): 153-60.
51. HERMANN E, ALONSO-VEGA C, BERTHE A, TRUYENS C, FLORES A, CÓRDOVA M, MORETTA L, TORRICO F, BRAUD V, CARLIER Y. (2006) Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells. Pediatr Res. 60(1): 38-43.
52. HERMANN E, TRUYENS C, ALONS-OVEGA C, EVEN J, RODRIGUEZ P, BERTHE A, GONZALEZ-MERINO E, TORRICO F, CARLIER Y. (2002) Human fetuses are able to mount an adultlike CD8 T-cell response. Blood. 100(6): 2153-8.
53. HERMANN E, TRUYENS C, ALONSO-VEGA C, RODRÍGUEZ P, BERTHE A, TORRICO F, CARLIER Y. (2004) Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferongamma in response to parasite antigens. J Infect Dis. 189(7): 1274-81.
54. HIGUCHI ML, FUKASAWA S, DE BRITO T, PARZIANELLO LC, BELLOTTI G, RAMIRES JA. (1999) Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart. 82(3): 279-85.
55. JAISWAL JK, ANDREWS NW, SIMON SM. (2002) Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol. 159(4): 625-35.
56. JAMES JL, STONE PR, CHAMLEY LW. (2006) The effects of oxygen concentration and gestational age on extravillous trophoblast outgrowth in a human first trimester villous explant model. Hum Reprod. 21(10): 2699-705. Epub 2006 Jun 28.
57. JUNQUEIRA LC AND CARNEIRO J. (2005) Basic Histology: Text and Atlas 11 edition McGraw-Hill Company
58. KIRCHHOFF LV. (1993) American trypanosomiasis (Chagas' disease) a tropical disease now in the United States. N Engl J Med 329: 639-44.
59. KIRCHHOFF, L.V. (1999) Chagas disease (American Trypanosomiasis): a tropical disease now emerging in the United States. In: Emerging Infections 3 (Scheld, W.M. et al., eds), pp. 111-134, ASM Press
60. KOI H, ZHANG J, PARRY S. (2001) The Mechanisms of Placental Viral Infection Ann N Y Acad Sci. 943: 148-56.
61. KUMAR V, ABBAS AK, FAUSTO N. (2005) Robbins and Cotran Pathologic Basis of Disease. 7th ed. St. Louis, Mo: WB Saunders
62. LESCURE FX, CANESTRI A, MELLIEZ H, JAUREGUIBERRY S, DEVELOUX M, DORENT R, GUIARD-SCHMID JB, BONNARD P, AJANA F, ROLLA V, CARLIER Y, GAY F, ELGHOUZZI MH, DANIS M, PIALOUX G. (2008) Chagas Disease, France. Emerg Infect Dis. 14(4): 644-646.
63. LIMA AP, ALMEIDA PC, TERSARIOL IL, SCHMITZ V, SCHMAIER AH, JULIANO L, HIRATA IY, MULLER-ESTERL W, CHAGAS JR, SCHARFSTEIN J. (2002) Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. J Biol Chem. 277(8): 5875-81.
64. LIN S, SARTORI MJ, MEZZANO L, DE FABRO SP. (2004) Epidermal growth factor (EGF) in the human placental infection with Trypanosoma cruzi. Placenta. 25(4): 283-6.
65. LIN S, SARTORI MJ, MEZZANO L, DE FABRO SP. (2005) Placental alkaline phosphatase (PLAP) enzyme activity and binding to IgG in Chagas' disease. Placenta. 26(10): 789-95.
66. LUJAN CD, TRIQUELL MF, SEMBAJ A, GUERRERO CE, FRETES RE. (2004) Trypanosoma cruzi: productive infection is not allowed by chorionic villous explant from normal human placenta in vitro. Exp Parasitol. 108(3-4): 176-81.
67. MACHADO FS, MARTINS GA, ALIBERTI JC, MESTRINER FL, CUNHA FQ, SILVA JS. (2000) Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxidedependent trypanocidal activity. Circulation. 102(24): 3003-8.
68. MAGALHAES JB, ANDRADE SG, SHERLOCK I. (1996) Trypanosoma cruzi strains: behavior after passage into authoctonous or foreign species of traitomine (biological and biochemical patterns). Rev Inst Med Trop Sao Paulo. 38(1): 23-8.
69. MAGDESIAN MH, GIORDANO R, ULRICH H, JULIANO MA, JULIANO L, SCHUMACHER RI, COLLI W, ALVES MJ. (2001) Infection by Trypanosoma cruzi. Identification of a parasite ligand and its host cell receptor. J Biol Chem. 276(22): 19382-9.
70. MANOEL-CAETANO FDA S, SILVA AE. (2007) Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease. Cad Saude Publica. 23(10): 2263-74.
71. MANQUE PM, NEIRA I, ATAYDE VD, CORDERO E, FERREIRA AT, DA SILVEIRA JF, RAMIREZ M, YOSHIDA N. (2003) Cell adhesion and Ca2+ signaling activity in stably transfected Trypanosoma cruzi epimastigotes expressing the metacyclic stagespecific surface molecule gp82. Infect Immun. 71(3): 1561-5.
72. MARGONO F, MROUEH J, GARELY A, WHITE D, DUERR A, MINKOFF HL. (1994) Resurgence of active tuberculosis among pregnant women. Obstet Gynecol.83(6): 911-4.
73. MARINO AP, SILVA AA, PINHO RT, LANNES-VIEIRA J. (2003) Trypanosoma cruzi infection: a continuous invader-host cell cross talk with participation of extracellular matrix and adhesion and chemoattractant molecules. Braz J Med Biol Res. 36(8): 1121-33.
74. MAYA JD, CASSELS BK, ITURRIAGA-VASQUEZ P, FERREIRA J, FAUNDEZ M, GALANTI N, FERREIRA A, MORELLO A. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp Biochem Physiol A Mol Integr Physiol. 2007 Apr;146(4): 601-20.
75. MENDES-DA-CRUZ DA, SILVA JS, COTTA-DE-ALMEIDA V, SAVINO W. (2006) Altered thymocyte migration during experimental acute Trypanosoma cruzi infection: combined role of fibronectin and the chemokines CXCL12 and CCL4. Eur J Immunol. 36(6): 1486-93.
76. MEZZANO L, SARTORI MJ, LIN S, REPOSSI G, DE FABRO SP. (2005) Placental alkaline phosphatase (PLAP) study in diabetic human placental villi infected with Trypanosoma cruzi. Placenta. 26(1): 85-92.
77. MOORE KL AND PERSEAUD TVN. (2004) The Developing Human, Clinically Oriented Embryology 7° edition Elsevier
78. MORELLO, A., LETELIER, M.E., ALDUNATE, J. AND REPETTO, Y. (1987). Enfermedad de Chagas, biotransformacion de xenobioticos por el Trypanosoma cruzi. In: Estudios en honor de Gustavo Hoecker. Auch 14: 33-48.
79. MUKHERJEE S, HUANG H, PETKOVA SB, ALBANESE C, PESTELL RG, BRAUNSTEIN VL, CHRIST GJ, WITTNER M, LISANTI MP, BERMAN JW, WEISS LM, TANOWITZ HB. (2004) Trypanosoma cruzi infection activates extracellular signalregulated kinase in cultured endothelial and smooth muscle cells. Infect Immun. 72(9): 5274-82.
80. NAGAJYOTHI F, DESRUISSEAUX M, BOUZAHZAH B, WEISS LM, ANDRADE DDOS S, FACTOR SM, SCHERER PE, ALBANESE C, LISANTI MP, TANOWITZ HB. (2006) Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle 5(1):107-12.
81. NAGASE H, WOESSNER JF JR. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-4.
82. NDE PN, SIMMONS KJ, KLESHCHENKO YY, PRATAP S, LIMA MF, VILLALTA F. (2006) Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection. Infect Immun. 74(3): 1643-8.
83. NISIDA IVV, AMATO-NETO V, BRAZ LMA, DUARTE MIS, UMEZAWA ES. (1999) A survey of congenital Chagas' disease, carried out at three health institutions in Sao Paolo City, Brazil. Rev Inst Med Trop Sao Paulo 41: 305-11.
84. ORTEGA-BARRIA E, PEREIRA ME. (1991) A novel T. cruzi heparinbinding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells. Cell. 67(2): 411-21.
85. OUAISSI MA, CORNETTE J AND CAPRON A. (1986) Identification and isolation of Trypanosoma cruzi trypomastigote cell surface protein with properties expected of a fibronectin receptor. Mol Biochem Parasitol 19: 201-211.
86. OPDENAKKER G, VAN DEN STEEN PE, DUBOIS B (2001) Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol; 69: 851-9.
87. OUAISSI MA, CORNETTE J, CAPRON A. (1985) Trypanosoma cruzi: modulation of parasite-cell interaction by plasma fibronectin. Eur J Immunol. 15(11): 1096-101.
88. PRATA A. (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. Sep;1(2): 92-100.
89. RAGHUPATHY R, KALINKA J. (2008) Cytokine imbalance in pregnancy complications and its modulation. Front Biosci. 1;13: 985-94.
90. RAGHUPATHY R. (2001) Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 13(4): 219-27.
91. ROBINSON NJ, WAREING M, HUDSON NK, BLANKLEY RT, BAKER PN, APLIN JD, CROCKER IP. (2008) Oxygen and the liberation of placental factors responsible for vascular compromise. Lab Invest. 88(3): 293-305.
92. ROCHA G, MARTINS A, GAMA G, BRANDAO F, ATOUGUIA J. (2004) Possible cases of sexual and congenital transmission of sleeping sickness. Lancet. 17;363(9404): 247.
93. RODRÍGUEZ A, MARTÍNEZ I, CHUNG A, BERLOT CH, ANDREWS NW. (1999) cAMP regulates Ca2+-dependent exocytosis of lysosomes and lysosome-mediated cell invasion by trypanosomes. J Biol Chem. 274(24): 16754-9.
94. RODRIGUEZ A, RIOULT MG, ORA A, ANDREWS NW. (1995) A trypanosome-soluble factor induces IP3 formation, intracellular Ca2+ mobilization and microfilament rearrangement in host cells. J Cell Biol. 129(5): 1263-73.
95. ROGERSON SJ, HVIID L, DUFFY PE, LEKE RF, TAYLOR DW. (2007) Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 7(2): 105-17.
96. ROPERT C, ALMEIDA IC, CLOSEL M, TRAVASSOS LR, FERGUSON MA, COHEN P, GAZZINELLI RT. (2001) Requirement of mitogenactivated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J Immunol. 166(5): 3423-31.
97. SALAS C, TAPIA RA, CIUDAD K, ARMSTRONG V, ORELLANA M, KEMMERLING U, FERREIRA J, MAYA JD, MORELLO A. (2008) Trypanosoma cruzi: activities of lapachol and alpha- and betalapachone derivatives against epimastigote and trypomastigote forms. Bioorg Med Chem. 16(2): 668-74.
98. SANTANA JM, GRELLIER P, SCHREVEL J, TEIXEIRA AR. (1997) A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem J. 325 (Pt 1): 129-37.
99. SARTORI MJ, MEZZANO L, LIN S, REPOSSI G, FABRO SP. (2005) Cellular components and placental alkaline phosphatase in Trypanosoma cruzi infection Rev Soc Bras Med Trop. 38 Suppl 2: 87-91.
100. SARTORI MJ, PONS P, MEZZANO L, LIN S, DE FABRO SP. (2003) Trypanosoma cruzi infection induces microfilament depletion in human placenta syncytiotrophoblast. Placenta. 24(7): 767-71.
101. SCHARFSTEIN J, MORROT A. (1999) A role for extracellular amastigotes in the immunopathology of Chagas disease. Mem Inst Oswaldo Cruz. 94 Suppl 1: 51-63.
102. SCHARFSTEIN J, SCHMITZ V, MORANDI V, CAPELLA MM, LIMA AP, MORROT A, JULIANO L, MULLER-ESTERL W. (2000) Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med. 192(9): 1289-300.
103. SCHMUNIS GA. (2007) Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 30;102 Suppl 1: 75-85.
104. SEEHO SK, PARK JH, ROWE J, MORRIS JM, GALLERY ED. (2008) Villous explants culture using early gestation tissue from ongoing pregnancies with known normal outcomes: the effect of oxygen on trophoblast outgrowth and migration. Hum Reprod. 23(5): 1170-9.
105. SHIPPEY SH III, ZAHN CM, CISAR MM, WU TJ, SATIN AJ. (2005) Use of the placental perfusion model to evaluate transplacental passage of Trypanosoma cruzi. Am J Obstet Gynecol. 192(2): 586-91.
106. SOARES MB, PONTES-DE-CARVALHO L AND RIBEIRO-DOS-SANTOS R (2001) The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Cienc 73: 547-559.
107. TDR PUBLICATIONS, REPORTS AND INFORMATIONAL MATERIAL: Reporte sobre la enfermedad de Chagas Grupo de trabajo cientifico 17-20 de abril de (2005) Actualizado en julio de 2007 Buenos Aires, Argentina http://www.who.int/tdr/publications/publications/swg_chagas.htm
108. TRIQUELL MF, DÍAZ-LUJAN C, FREILIJ H, PAGLINI P, FRETES RE. Placental infection by two subpopulations of Trypanosoma cruzi is conditioned by differential survival of the parasite in a deleterious placental medium and not by tissue reproduction. Trans R Soc Trop Med Hyg (2009), doi: 10.1016/j.trstmh.2009.03.004
109. TODOROV AG, EINICKER-LAMAS M, DE CASTRO SL, OLIVEIRA MM, GUILHERME A. (2000) Activation of host cell phosphatidylinositol 3-kinases by Trypanosoma cruzi infection. J Biol Chem. 275(41): 32182-6.
110. TORRICO F, CASTRO M, SOLANO M, RODRÍGUEZ P, TORRICO MC, TRUYENS C, CARLIER Y. (2005) Effects of maternal infection with Trypanosoma cruzi in pregnancy development and in the newborn infant Rev Soc Bras Med Trop.38 Suppl 2: 73-6.
111. TORRICO F, VEGA CA, SUAREZ E, TELLEZ T, BRUTUS L, RODRÍGUEZ P, TORRICO MC, SCHNEIDER D, TRUYENS C, CARLIER Y. (2006) Are maternal reinfections with Trypanosoma cruzi associated with higher morbidity and mortality of congenital Chagas disease? Trop Med Int Health. 11(5): 628-35.
112. TRUYENS C, HERMANN E, ALONSO-VEGA C, RODRÍGUEZ P, VEKEMANS J, TORRICO F, CARLIER Y. (2005) Immune responses of non-infected neonates of mothers infected with Trypanosoma cruzi Rev Soc Bras Med Trop. 38 Suppl 2: 96-100.
113. ULRICH H, MAGDESIAN MH, ALVES MJ, COLLI W. (2002) In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem. 277(23): 20756-62.
114. VAENA DE ÁVALOS S, BLADER IJ, FISHER M, BOOTHROYD JC, BURLEIGH BA. (2002) Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J Biol Chem. 277(1): 639-44.
115. VIEIRA M, DUTRA JM, CARVALHO TM, CUNHAE-SILVA NL, SOUTOPADRON T AND SOUZA W. (2002) Cellular signaling during the macrophage invasion by Trypanosoma cruzi. Histochem Cell Biol 118: 491-500.
116. VIEIRA MC, DE CARVALHO TU, DE SOUZA W. (1994) Effect of protein kinase inhibitors on the invasion process of macrophages by Trypanosoma cruzi. Biochem Biophys Res Commun. 203(2): 967-71.
117. VILLALTA F, ZHANG Y, BIBB KE, BURNS JM JR, LIMA MF. (1998) Signal transduction in human macrophages by gp83 ligand of Trypanosoma cruzi: trypomastigote gp83 ligand up-regulates trypanosome entry through the MAP kinase pathway. Biochem Biophys Res Commun. 249(1): 247-52.
118. VILLALTA F, ZHANG Y, BIBB KE, PRATAP S, BURNS JM JR, LIMA MF. (1999) Signal transduction in human macrophages by gp83 ligand of Trypanosoma cruzi: trypomastigote gp83 ligand up-regulates trypanosome entry through protein kinase C activation. Mol Cell Biol Res Commun. 2(1): 64-70.
119. WERB Z, SYMPSON CJ, ALEXANDER CM, THOMASSET N, LUND LR, MACAULEY A (1996) Extracellular matrix remodeling and the regulation of epithelialstromal interactions during differentiation and involution. Kidney Int 54 (Suppl: S) 68-74.
120. WILKOWSKY SE, BARBIERI MA, STAHL P, ISOLA EL. (2001) Trypanosoma cruzi: phosphatidylinositol 3-kinase and protein kinase B activation is associated with parasite invasion. Exp Cell Res. 264(2): 211-8.
121. WIRTH JJ, KIERSZENBAUM F. (1984) Fibronectin enhances macrophage association with invasive forms of Trypanosoma cruzi. J Immunol. 133(1): 460-4.
122. WOOLSEY AM, BURLEIGH BA (2004) Host cell actin polymerization is required for cellular retention of Trypanosoma cruzi and early association with endosomal/lysosomal compartments. Cell Microbiol. 6(9): 829-38.
123. WORLD HEALTH ORGANIZATION. Control of Chagas' disease. Report of the WHO Expert Committee. World Health Organ Tech Rep Series (2002);905.
124. WORLD HEALTH ORGANIZATION Department of Control of Neglected Tropical Diseases www.who.int/neglected_diseases (2009)
125. YOSHIDA N. (2006) Molecular basis of mammalian cell invasion by Trypanosoma cruzi. An Acad Bras Cienc. 78(1): 87-111.
126. YOSHIDA N. (2008) Trypanosoma cruzi infection by oral route How the interplay between parasite and host components modulates infectivity. Parasitol Int 57(2): 105-9.
127. ZHONG L, LU HG, MORENO SN, DOCAMPO R. (1998) Tyrosine phosphate hydrolysis of host proteins by Trypanosoma cruzi is linked to cell invasion. FEMS Microbiol Lett. 161(1): 15-20.